Gastroenterology clinics have a structural advantage among internal medicine practices: endoscopy can serve as the revenue pillar. Against an average independent internal medicine physician income of roughly ¥24.2 million, gastroenterology clinics accumulate upper and lower endoscopy fees (cited in secondary sources at roughly 1,140 points for upper and 900–1,550 for lower), which tends to push income above other internal medicine fields.
The trade-off is heavy specialized equipment investment. Initial capital and fixed costs sit clearly above a general internal medicine practice.
1. Macro environment — FY2026 revision issues
The main FY2026 revision points affecting gastroenterology clinics are summarized below (all from secondary sources; verify against primary notifications).
| Issue | Reported content | Implication for clinics |
|---|---|---|
| Lifestyle disease management fee (I)(II) | Blood testing at least once every six months becomes mandatory. New ophthalmology/dental coordination add-ons (60 points each) | Requirements for primary care functions alongside endoscopy are strengthening |
| Specific disease treatment management fee | Excluded when NSAIDs are prescribed to peptic ulcer patients | A billing requirement change directly touching gastroenterology |
| Online consultation | New remote electronic prescription add-on (10 points) | Fits online post-eradication follow-up and mild return visits |
| Healthcare DX | Promotion and information acquisition add-ons consolidated into an "electronic clinical information coordination readiness add-on" (up to 15 points at first visit) | EMR and online eligibility verification become prerequisites |
Structurally, endoscopy offers clear per-case unit pricing and appointment-based slot planning, making revenue more predictable than a consultation-only clinic. In exchange, running costs — equipment renewal, reprocessing, scope inventory — and slot utilization become existential.
2. Characteristics of newly opened clinics
Recent endoscopy clinic openings deliberately combine a specialized model foregrounding upper and lower endoscopy with a general model covering broader gastrointestinal and lifestyle disease care. Testing alone narrows the patient base too much; covering GI disease broadly widens the everyday entry point and surfaces testing demand from there.
Location and hours: successful cases choose properties near stations with nearby facilities where patients can spend waiting time, and add full weekend hours to capture working-age patients who cannot take time off on weekdays.
Digital patient acquisition strongly determines ramp speed. A Sendai endoscopy clinic that shifted entirely from bus advertising to web marketing reportedly reached monthly profitability in three months and 400 endoscopies per month by month six — about ten times the cited industry average of 41. The differentiator was messaging around dispelling the "painful procedure" image. The numbers are a single case, but the combination of web-first acquisition, patient experience messaging, and specialized positioning is becoming the standard playbook.
Initial investment is heavier than general internal medicine: roughly ¥60–61 million, with tenants of 165–200 m² or larger preferred.
| Item | Typical range (secondary sources) |
|---|---|
| Property (deposits, etc.) | ¥8–12 million |
| Interior construction | ¥20–50 million |
| Medical equipment | ¥20–35 million |
| Opening preparation | ¥5–10 million |
| Working capital | ¥10–15 million |
3. Revenue areas specific to gastroenterology
Upper and lower endoscopy as the revenue pillar is what most distinguishes this field. Per-case pricing is clear and slots can be filled by plan, so utilization translates directly into revenue. Conversely, cancellation management, bowel preparation efficiency, and the design of scope inventory and reprocessing workflow determine earning power outright.
Comfortable (sedated) endoscopy is the most important differentiator for patient acquisition. Sedation, transnasal endoscopy, thin scopes, and CO2 insufflation are all commonly promoted. Sedation requires a recovery room and dwell time, making it inseparable from flow and throughput design.
Endoscopic AI (CADe/CADx) has spread to clinic-scale practices. AI that detects and highlights colorectal polyps in real time (EndoBRAIN-EYE, EIRL Colon Polyp and others) is adopted to reduce missed lesions while improving accuracy and lowering physician load. Some clinics cite manufacturer-published performance — 96.3% sensitivity, 93.7% specificity — as evidence of local technological leadership. The Japan Gastroenterological Endoscopy Society also explains AI use to the public. AI converts easily into acquisition messaging on both axes: reassurance about missed lesions, and clinical quality.
Gastric and colorectal cancer screening and H. pylori function as the entry point for testing demand. H. pylori testing and eradication are insured within defined scope, and since gastric cancer risk persists after eradication, clinics build pathways to regular endoscopic follow-up. Serving as the receiving site for municipal screening creates a continuous first visit → test → follow-up cycle.
Throughput design is both a revenue area and a risk. Design considerations include multiple procedure rooms, a recovery room, multiple dedicated toilets for bowel preparation, reprocessing and disinfection space, and equipment storage. Separating patient and staff flows and placing reprocessing adjacent to procedure rooms with a pass-through box is recommended. In short, daily capacity is the product of scopes × reprocessing capacity × procedure rooms × recovery dwell time — and whether that design is built in at opening defines the revenue ceiling.
4. Self-pay services
While insured endoscopy is the pillar, self-pay endoscopic and comprehensive health screening is established as a way to capture asymptomatic patients — those seeking cancer screening without symptoms, or wanting a specific appointment time. Being outside insurance, pricing is set by the clinic, unit values are clear, and it aligns well with health-conscious populations and corporate health programs.
One clinic publishes endoscopic screening at ¥16,500 (tax incl.) for upper endoscopy, ¥27,500 plus ¥2,200 for pre-consultation and medication for colonoscopy, and ¥44,000 for the combined package. Adding a urea breath test for H. pylori runs about ¥6,000 more — options stack onto the base price. Clinics also state clearly that if biopsy or polypectomy becomes necessary during screening, the encounter converts to insured care.
Hospital-affiliated screening centers and dedicated screening clinics compete in the same space, so clinics differentiate on "a specialist performs every case," comfort, AI-assisted detection, and same-day results explanation.
Two caveats. First, the insured/self-pay switch requires clearly defined operations and explanation. Second, unless price is backed by procedure experience, accuracy, and convenience, the market slides into price competition.
5. Management implications
First, insured endoscopy remains the pillar, but its ceiling is set by throughput design. Designing the scope-reprocessing-room-recovery product at opening, and building in cancellation management and preparation workflow, determines payback speed.
Second, the competitive front line has moved to comfort and AI. Sedated procedures and AI detection directly lower the two patient barriers — pain and fear of missed lesions — making them investments that convert readily into acquisition messaging.
Third, self-pay screening and concurrent lifestyle disease care are the two side pillars that dampen volatility. Self-pay screening has clear unit pricing and captures asymptomatic patients; concurrent lifestyle disease care supports continuity and satisfies the strengthened primary care requirements. Combining episodic testing with continuous outpatient management smooths revenue swings.
Fourth, given the heavy capital requirement, balancing investment scale against projected case volume before opening is the single most important decision.
6. How an AI EMR addresses these problems — feature by feature
Endoscopy clinics generate two kinds of writing in parallel: outpatient consultation notes (lifestyle disease, H. pylori, pre- and post-procedure explanation) and procedure findings. Because the bottleneck sits differently than in general internal medicine, the features that help differ too. Here is where Pottech's AI Karte lightens the load, feature by feature.
Feature 1: Booking and reception — slot utilization is revenue
In-person and online bookings are managed together, searchable instantly by patient name, phone number, or card number, with support for segmented slot management.
Endoscopy clinics run on scheduled slots, so one cancellation is one empty slot — zero revenue. For colonoscopy requiring bowel preparation, last-minute cancellations hit hardest and there is no time to refill. Reducing no-shows through web booking and reminders acts directly on equipment payback speed. And because sedated procedures occupy procedure and recovery rooms for different durations, uniform-interval booking breaks down. Slot management by patient type and duration is how throughput design gets enforced by the system rather than by memory.
Feature 2: Charting and orders — lighten pre/post-procedure documentation
AI generates SOAP notes from consultation audio, and web and paper questionnaires are digitized by camera. Set orders enter tests, prescriptions, and procedures in one action.
Procedure explanation, consent, and results discussion are highly templated and documentation-heavy — exactly where templates plus voice input pay off. Repetitive work such as prescribing preparation agents and confirming pre-procedure medication holds compresses into set orders. Capturing current medications, history, and anticoagulant use through a pre-visit web questionnaire reduces both same-day verification effort and the risk of procedure cancellation.
Feature 3: Integrations and APIs — consolidate endoscopy system data into the chart
An OAuth2 gateway, MCP server, and HAPI FHIR enable integration with external systems.
Endoscopy generates heterogeneous data: images, reports, and AI detection results. When these stay inside the endoscopy system, report writing and charting become duplicate entry. Whether test data and charts can be unified determines post-procedure administrative load and how fast results can be explained. If same-day results explanation is your self-pay differentiator, this integration is a prerequisite.
Feature 4: Billing and claims — never mishandle the insured/self-pay switch
An automated calculation engine checks bundling conflicts, exclusions, and frequency limits, and determines add-on eligibility automatically.
Endoscopy clinics have a distinctive accounting pattern: a procedure that begins as self-pay screening converts to insured care when biopsy or polypectomy becomes necessary. Because that switch touches the prohibition on mixed billing directly, operational mistakes are a business risk. Encoding billing logic in the system protects both compliance and accounting accuracy — as does handling gastroenterology-specific rules such as the exclusion of the specific disease treatment management fee when NSAIDs are prescribed to peptic ulcer patients.
Feature 5: Patient PHR app integration ("Pote-kun") — keep the screening cycle unbroken
OCR capture of prescriptions with medication reminders, pre-visit web questionnaires, and LINE login with push notifications.
Recurring revenue in gastroenterology rests on long-interval return cycles: regular endoscopic follow-up after eradication, surveillance after polypectomy, screening every one to two years. A mechanism that notifies the patient at the recommended interval one or two years out is the practical way to keep those long gaps from breaking. Notifications for preparation agent timing also affect procedure quality on the day.
Feature 6: Practice analytics — measure profitability per slot
Visit volume, revenue per patient, and monthly trends are aggregated and visualized automatically.
The operating metric for an endoscopy clinic is not patient count but slot utilization and gross margin per slot. Upper versus lower, sedated versus unsedated, insured versus self-pay screening — each differs in both duration and price, so slot allocation cannot be judged without segmented views. Precisely because capital investment is heavy, profitability per slot is the only meaningful payback metric.
Primary sources
- MHLW Shikoku Regional Bureau, "FY2026 fee schedule revision" https://kouseikyoku.mhlw.go.jp/shikoku/iryo_shido/shinryohosyu_r8_00001.html
- Yuyama, "Key points of the FY2026 revision for independent physicians" https://www.yuyama.co.jp/column/medicalrecord/revision-of-medical-fees-2026-2/
- All Japan Medical Management Research Association, "FY2026 revision: gastroenterology management guide" https://zen-ikei.co.jp/column/policy/4676/
- Wemex/Medicom, "How to avoid failure opening a gastroenterology clinic" https://www.phchd.com/jp/phcmn/service/column/article508
- Yokomatsu Architects, "Opening capital, property selection, and design points for endoscopy clinics" https://www.yokomatsu.info/blog/2025/11/17/202511-09-gastroenterology-clinic/
- Funai Consulting, "From hospital physician to clinic owner: Sendai endoscopy case" https://www.funaisoken.co.jp/voice/sendai-naisikyou
- Japan Gastroenterological Endoscopy Society, "Is AI used in endoscopy?" https://www.jges.net/citizen/faq/general_11
- Ezoe Gastroenterology Endoscopy Clinic, "Health screening pricing" https://www.ezoe-clinic.com/dock/